VM:CA:TSV-Voyageur Pharmaceuticals Ltd (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 0.135

Change

-0.01 (-3.57)%

Market Cap

USD 0.02B

Volume

0.46M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-14 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
RX:CA Biosyent Inc.

-0.34 (-3.04%)

USD 0.13B
SBBC:CA Simply Better Brands Corp

+0.07 (+6.25%)

USD 0.10B
HASH:CA Simply Solventless Concentrate..

-0.02 (-2.16%)

USD 0.07B
ZYUS:CA ZYUS Life Sciences Corporation

+0.02 (+2.44%)

USD 0.06B
LOVE:CA Cannara Biotech Inc

N/A

USD 0.06B
LSL:CA LSL Pharma Group Inc.

-0.02 (-3.85%)

USD 0.04B
DB:CA Decibel Cannabis Company Inc

+0.01 (+6.67%)

USD 0.04B
ROMJ:CA Rubicon Organics Inc

-0.02 (-4.65%)

USD 0.02B
PCLO:CA Pharmacielo Ltd

+0.01 (+10.00%)

USD 0.02B
ELXR:CA Elixxer Ltd

N/A

USD 0.01B

ETFs Containing VM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 58.82% 94% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.82% 94% A 94% A
Trailing 12 Months  
Capital Gain 58.82% 82% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.82% 82% B 84% B
Trailing 5 Years  
Capital Gain 80.00% 78% C+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 80.00% 78% C+ 82% B
Average Annual (5 Year Horizon)  
Capital Gain 12.77% 68% D+ 64% D
Dividend Return 12.77% 68% D+ 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 59.65% 47% F 45% F
Risk Adjusted Return 21.40% 74% C 71% C-
Market Capitalization 0.02B 58% F 71% C-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector